cilostazol has been researched along with cytochrome c-t in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lim, JH; Shin, YW; Woo, JS | 1 |
| Sun, C; Xie, X; Xu, X; Yu, Z | 1 |
2 other study(ies) available for cilostazol and cytochrome c-t
| Article | Year |
|---|---|
Cilostazol protects endothelial cells against lipopolysaccharide-induced apoptosis through ERK1/2- and P38 MAPK-dependent pathways.
Topics: Apoptosis; bcl-2-Associated X Protein; Caspases; Cell Line; Cell Survival; Cilostazol; Cyclic AMP Response Element-Binding Protein; Cytochromes c; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Lipopolysaccharides; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Tetrazoles; Time Factors | 2009 |
Protective effects of cilostazol on ethanol-induced damage in primary cultured hepatocytes.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Survival; Cells, Cultured; Cilostazol; Cytochromes c; Ethanol; Hepatocytes; Male; Mitochondria; Protective Agents; Rats, Sprague-Dawley; Reactive Oxygen Species | 2018 |